0.55 TWD
22.29 M TWD
889.91 M TWD
115.13 M
About ORIENT PHARMA CO LTD
Sector
CEO
Chi Tai Chang
Headquarters
Taipei
Website
Founded
2008
ISIN
TW0004166004
FIGI
BBG0033966J0
Orient Pharma Co., Ltd. engages in the research, development, and production of pharmaceutical products. Its products include anti-psychotics, drugs for treating Alzheimer's disease, psychostimulants, and drugs for treating Parkinson's disease. The company was founded on February 1, 2008 and is headquartered in Taipei, Taiwan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4166 is 37.00 TWD — it has decreased by −0.27% in the past 24 hours. Watch ORIENT PHARMA CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange ORIENT PHARMA CO LTD stocks are traded under the ticker 4166.
4166 stock has fallen by −7.50% compared to the previous week, the month change is a −5.49% fall, over the last year ORIENT PHARMA CO LTD has showed a 80.93% increase.
4166 reached its all-time high on Oct 31, 2013 with the price of 142.10 TWD, and its all-time low was 11.55 TWD and was reached on Mar 23, 2020. View more price dynamics on 4166 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4166 stock is 3.45% volatile and has beta coefficient of 0.03. Track ORIENT PHARMA CO LTD stock price on the chart and check out the list of the most volatile stocks — is ORIENT PHARMA CO LTD there?
Today ORIENT PHARMA CO LTD has the market capitalization of 8.25 B, it has increased by 1.88% over the last week.
Yes, you can track ORIENT PHARMA CO LTD financials in yearly and quarterly reports right on TradingView.
4166 net income for the last half-year is 97.01 M TWD, while the previous report showed 22.09 M TWD of net income which accounts for 339.26% change. Track more ORIENT PHARMA CO LTD financial stats to get the full picture.
No, 4166 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ORIENT PHARMA CO LTD EBITDA is 280.92 M TWD, and current EBITDA margin is 17.97%. See more stats in ORIENT PHARMA CO LTD financial statements.
Like other stocks, 4166 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ORIENT PHARMA CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ORIENT PHARMA CO LTD technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ORIENT PHARMA CO LTD stock shows the buy signal. See more of ORIENT PHARMA CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.